Literature DB >> 24117670

Diffuse lung disease in infancy and childhood: expanding the chILD classification.

Alexandra Rice1, My-Anh Tran-Dang, Andrew Bush, Andrew G Nicholson.   

Abstract

AIMS: Diffuse parenchymal lung diseases (DPLD) in children comprise a wide spectrum of rare disorders. In 2007 the Children's Interstitial Lung Disease (chILD) Research Cooperative proposed a classification system for DPLD in children <2 years of age. The aims of our study were to determine the utility and reproducibility of this system in children <2 years of age, and test its extension to 18 years of age. METHODS AND
RESULTS: Of 211 cases, 93 were <2 years of age at presentation and 58% were included in the chILD classification. In 118 cases aged between 2 and 18 years there was a wider distribution of disorders, overlapping with those seen in adults, necessitating expansion of the chILD classification types to encompass all reviewed cases, in particular patients with 'adult' diffuse lung diseases. Many cases showed mixed histological patterns, overlap often being between groups of disorders more prevalent in infancy. Concordance between reporting pathologists was 90%.
CONCLUSIONS: The chILD scheme allows classification of conditions more common in children <2 years of age. It can be applied to children of any age, although additional entities need to be included. We propose a more histologically based system for use when assessing biopsies in this context.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  chILD classification; interstitial lung disease; paediatric

Mesh:

Year:  2013        PMID: 24117670     DOI: 10.1111/his.12185

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  19 in total

Review 1.  Interstitial lung disease in children.

Authors:  Christin S Kuo; Lisa R Young
Journal:  Curr Opin Pediatr       Date:  2014-06       Impact factor: 2.856

2.  Diffuse Lung Disease in Biopsied Children 2 to 18 Years of Age. Application of the chILD Classification Scheme.

Authors:  Leland L Fan; Megan K Dishop; Csaba Galambos; Frederic B Askin; Frances V White; Claire Langston; Deborah R Liptzin; Miranda E Kroehl; Gail H Deutsch; Lisa R Young; Geoffrey Kurland; James Hagood; Sharon Dell; Bruce C Trapnell; Robin R Deterding
Journal:  Ann Am Thorac Soc       Date:  2015-10

Review 3.  Interstitial lung disease in newborns.

Authors:  Lawrence M Nogee
Journal:  Semin Fetal Neonatal Med       Date:  2017-03-28       Impact factor: 3.926

4.  Surfactant proteins in pediatric interstitial lung disease.

Authors:  Matthias Griese; Elke Lorenz; Meike Hengst; Andrea Schams; Traudl Wesselak; Daniela Rauch; Thomas Wittmann; Valerie Kirchberger; Amparo Escribano; Thomas Schaible; Winfried Baden; Johannes Schulze; Heiko Krude; Charalampos Aslanidis; Nicolaus Schwerk; Matthias Kappler; Dominik Hartl; Peter Lohse; Ralf Zarbock
Journal:  Pediatr Res       Date:  2015-09-16       Impact factor: 3.756

Review 5.  Update on Diffuse Lung Disease in Children.

Authors:  Timothy J Vece; Lisa R Young
Journal:  Chest       Date:  2016-01-12       Impact factor: 9.410

6.  Spectrum of childhood interstitial and diffuse lung diseases at a tertiary hospital in Egypt.

Authors:  Salma G Abdelhady; Eman M Fouda; Malak A Shaheen; Faten A Ghazal; Ahmed M Mostafa; Ahmed M Osman; Andrew G Nicholson; Heba M Hamza
Journal:  ERJ Open Res       Date:  2021-06-07

7.  Categorizing diffuse parenchymal lung disease in children.

Authors:  Matthias Griese; Armin Irnstetter; Meike Hengst; Helen Burmester; Felicitas Nagel; Jan Ripper; Maria Feilcke; Ingo Pawlita; Florian Gothe; Matthias Kappler; Andrea Schams; Traudl Wesselak; Daniela Rauch; Thomas Wittmann; Peter Lohse; Frank Brasch; Carolin Kröner
Journal:  Orphanet J Rare Dis       Date:  2015-09-25       Impact factor: 4.123

8.  Characterization of CSF2RA mutation related juvenile pulmonary alveolar proteinosis.

Authors:  Jenna Hildebrandt; Ebru Yalcin; Hans-Georg Bresser; Guzin Cinel; Monika Gappa; Alireza Haghighi; Nural Kiper; Soheila Khalilzadeh; Karl Reiter; John Sayer; Nicolaus Schwerk; Anke Sibbersen; Sabine Van Daele; Georg Nübling; Peter Lohse; Matthias Griese
Journal:  Orphanet J Rare Dis       Date:  2014-11-26       Impact factor: 4.123

9.  Surfactant lipidomics in healthy children and childhood interstitial lung disease.

Authors:  Matthias Griese; Hannah G Kirmeier; Gerhard Liebisch; Daniela Rauch; Ferdinand Stückler; Gerd Schmitz; Ralf Zarbock
Journal:  PLoS One       Date:  2015-02-18       Impact factor: 3.240

10.  Congenital Deletion of Nedd4-2 in Lung Epithelial Cells Causes Progressive Alveolitis and Pulmonary Fibrosis in Neonatal Mice.

Authors:  Dominik H W Leitz; Julia Duerr; Surafel Mulugeta; Ayça Seyhan Agircan; Stefan Zimmermann; Hiroshi Kawabe; Alexander H Dalpke; Michael F Beers; Marcus A Mall
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.